Therapeutic approaches to reduce systemic inflammation in septic-associated neurologic complications

European Journal of Anaesthesiology

Volumn 25, Issue SUPPL. 42, 2008, Pages 1-7

  Wratten, M L ^a  

^a Cyberonics Inc   (Italy)

Author keywords

Cytokines; Encephalopathy; Filtration, plasma; Sepsis

Indexed keywords

CYTOKINE;

BLOOD BRAIN BARRIER; BRAIN DISEASE; COGNITION; CYTOKINE PRODUCTION; HUMAN; IMMUNOMODULATION; INTENSIVE CARE; MORTALITY; NEUROLOGICAL COMPLICATION; PATHOPHYSIOLOGY; PLASMAPHERESIS; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ADSORPTION; ANIMAL; EQUIPMENT DESIGN; HEMOFILTRATION; INFECTION; INFLAMMATION; METABOLISM; NEUROLOGIC DISEASE; SIGNAL TRANSDUCTION;

ADSORPTION; ANIMALS; BLOOD-BRAIN BARRIER; CYTOKINES; EQUIPMENT DESIGN; HEMOFILTRATION; HUMANS; INFECTION; INFLAMMATION; NERVOUS SYSTEM DISEASES; SEPSIS; SIGNAL TRANSDUCTION;

EID: 43149104761     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507003444     Document Type: Review

References (47)

1. Dombrowskiy V, Martin A, Sunderram J, Paz H. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007; 35: 1244-1245.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
3. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150.
4. Russell JA. Management of sepsis. N Engl J Med 2006; 355: 1699-1713.
5. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest 2003; 112: 460-467.
6. Ronco C, Tetta C, Mariano F et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003; 27: 792-801.
7. Imai Y, Parodo J, Kajikawa O et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003; 289: 2104-2112.
8. Munford R, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001; 163: 316-321.
9. Consales G, De Gaudio AR. Sepsis associated encephalopathy. Minerva Anestesiol 2005; 71: 39-52.
10. Sharshar T, Hopkinson NS, Orlikowski D, Annane D. Science review: The brain in sepsis - culprit and victim. Crit Care 2005; 9: 37-44.
11. Wilson JX, Young GB. Progress in clinical neurosciences: sepsis-associated encephalopathy: evolving concepts. Can J Neurol Sci 2003; 30: 98-105.
12. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol 1993; 33: 94-100.
13. Young GB, Bolton CF, Austin TW, Archibald YM, Gonder J, Wells GA. The encephalopathy associated with septic illness. Clin Invest Med 1990; 13: 297-304.
14. Papadopoulos MC, Davies DC, Moss RF, Tighe D, Bennett ED. Pathophysiology of septic encephalopathy: a review. Crit Care Med 2000; 28: 3019-3024.
15. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003; 126: 1015-1025.
16. Barlas I, Oropello JM, Benjamin E. Neurologic complications in intensive care. Curr Opin Crit Care 2001; 7: 68-73.
17. Sprung CL, Peduzzi PN, Shatney CH et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 1990; 18: 801-806.
18. Young GB, Bolton CF, Archibald YM, Austin TW, Wells GA. The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 1992; 9: 145-152.
19. Nguyen DN, Spapen H, Su F et al. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med 2006; 34: 1967-1974.
20. Stocchetti N. Brain and sepsis: functional impairment, structural damage, and markers. Anesth Analg 2005; 101: 1463-1464.
21. Davies DC. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 2002; 200: 639-646.
22. du Moulin GC, Paterson D, Hedley-Whyte J, Broitman SA. E. coli peritonitis and bacteremia cause increased blood-brain barrier permeability. Brain Res 1985; 340: 261-268.
23. Papadopoulos MC, Lamb FJ, Moss RF, Davies DC, Tighe D, Bennett ED. Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci (Lond) 1999; 96: 461-466.
24. Nassif X, Bourdoulous S, Eugene E, Couraud PO. How do extracellular pathogens cross the blood-brain barrier? Trends Microbiol 2002; 10: 227-232.
25. Estrada RV, Moreno J, Martinez E, Hernandez MC, Gilsanz G, Gilsanz V. Pancreatic encephalopathy. Acta Neurol Scand 1979; 59: 135-139.
26. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Francoise G. The neuropathology of septic shock. Brain Pathol 2004; 14: 21-33.
27. Moss R, Parmar N, Tighe D, Davies D. Adrenergic agents modify cerebral edema and microvessel ultrastructure in porcine sepsis. Crit Care Med 2004; 32: 1916-1921.
28. Hinkelbein J, Schroeck H, Peterka A, Schubert C, Kuschinsky W, Kalenka A. Local cerebral blood flow is preserved in sepsis. Curr Neurovasc Res 2007; 4: 39-47.
29. Rosengarten B, Hecht M, Auch D et al. Microcirculatory dysfunction in the brain precedes changes in evoked potentials in endotoxin-induced sepsis syndrome in rats. Cerebrovasc Dis 2007; 23: 140-147.
30. Cojocaru IM, Musuroi C, Iacob S, Cojocaru M. Investigation of TNF-alpha, IL-6, IL-8 and of procalcitonin in patients with neurologic complications in sepsis. Rom J Intern Med 2003; 41: 83-93.
31. Paul R, Koedel U, Winkler F et al. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain 2003; 126: 1873-1882.
32. Rupprecht TA, Angele B, Klein M et al. Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system. J Immunol 2007; 178: 1861-1869.
33. Swiergiel AH, Dunn AJ. Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav 2007; 86: 651-659.
34. Dunn AJ, Swiergiel AH. The role of cytokines in infection-related behavior. Ann NY Acad Sci 1998; 840: 577-585.
35. Krueger JM,Walter J, Dinarello CA,Wolff SM, Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol 1984; 246: R994-R999.
36. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann NY Acad Sci 2001; 933: 222-234.
37. Serantes R, Arnalich F, Figueroa M et al. Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy. J Biol Chem 2006; 281: 14632-14643.
38. Moller K, Strauss GI, Qvist J et al. Cerebral blood flow and oxidative metabolism during human endotoxemia. J Cereb Blood Flow Metab 2002; 22: 1262-1270.
39. Tsao N, Hsu HP, Wu CM, Liu CC, Lei HY. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol 2001; 50: 812-821.
40. Bouman CS, Oudemans-van Straaten HM, Schultz MJ, Vroom MB. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. J Crit Care 2007; 22: 1-12.
41. Muirhead E, Reid A. Resin Artificial Kidney. J Lab Clin Med 1948; 33: 841-844.
42. Winchester JF, Silberzweig J, Ronco C et al. Sorbents in acute renal failure and endstage renal disease: middle molecule and cytokine removal. Blood Purif 2004; 22: 73-77.
43. Howell CA, Sandeman SR, Phillips GJ et al. The in vitro adsorption of cytokines by polymer-pyrolysed carbon. Biomaterials 2006; 27: 5286-5291.
44. Ronco C, Brendolan A, d'Intini V, Ricci Z, Wratten ML, Bellomo R. Coupled plasma filtration adsorption: rationale, technical development and early clinical experience. Blood Purif 2003; 21: 409-416.
45. Ronco C, Brendolan A, Lonnemann G et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002; 30: 1250-1255.
46. Mariano F, Tetta C, Stella M, Biolino P, Miletto A, Triolo G. Regional citrate anticoagulation in critically ill patients treated with plasma filtration and adsorption. Blood Purif 2004; 22: 313-319.
47. Formica M, Olivieri C, Livigni S et al. Hemodynamic response to coupled plasma filtration-adsorption in human septic shock. Intensive Care Med 2003; 29: 703-708.